Concepedia

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse, Yoshitomo Okajima, Shunji Kurotobi, Katsuki Hirai, Takashi Soga, Yukiko Ishiguchi, Yoshiaki Okuma, Nobuyuki Takada,

The Lancet · 2019 · 208 citations · 25 references

DOI

Concepts

References

25

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

Jane W. Newburger, Masato Takahashi, Jane C. Burns et al. · New England Journal of Medicine · 1986 · 1.4K citations

, , +10

[Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Tomisaku Kawasaki · PubMed · 1967 · 1.4K citations

, , +11

Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease

Tohru Kobayashi, Yoshinari Inoue, Kazuo Takeuchi et al. · Circulation · 2006 · 911 citations

, , +14

Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial

Tohru Kobayashi, Tsutomu Saji, Tetsuya Otani et al. · The Lancet · 2012 · 674 citations

, , +11

Revision of diagnostic guidelines for Kawasaki disease (6th revised edition)

Tohru Kobayashi, Mamoru Ayusawa, Hiroyuki Suzuki et al. · Pediatrics International · 2020 · 597 citations

, , +5